AnjleeSakaria

Associate

London + 44.20.7039.5228

Anjlee Sakaria's practice covers a range of contentious and transactional intellectual property matters, including patents, trademarks, copyright, domain names, and confidential information.

Anjlee's experience in contentious matters includes high-value, multijurisdictional patent disputes for some of the world's leading companies, primarily in the pharmaceutical and biotechnology industries. Her scientific background includes a degree in neuroscience.

Anjlee also assists with regulatory areas that impact commercial law and technology, including data protection and privacy issues. In 2018 she served a secondment with ICBC Standard Bank to assist the bank with such issues.

Experience

  • Macquarie sold Condor FerriesJones Day advised Macquarie Infrastructure and Real Assets in the sale of Condor Ferries, an operator of lifeline freight and passenger ferry services between Guernsey, Jersey, the United Kingdom, and the Port of St. Malo in France, to a consortium of Columbia Threadneedle European Sustainable Infrastructure Fund (ESIF) and Brittany Ferries.
  • Goldman to sell iQ Student Accommodation dorms to Blackstone for £4.66 billionJones Day is representing Goldman Sachs and The Wellcome Trust in connection with the £4.66 billion sale of the UK focused iQ Student Accommodation student housing property portfolio and business to Blackstone.
  • Sumitomo Heavy Industries invests $46 million into Highview PowerJones Day advised Sumitomo Heavy Industries, Ltd., a technology leader in industrial machinery and environmental and power technologies, in its $46 million investment into Highview Power, a global leader in long-duration energy storage solutions.
  • Procter & Gamble to acquire Billie Inc.Jones Day is advising The Procter & Gamble Company (NYSE: PG) in its acquisition of Billie Inc., a direct-to-consumer seller of female shaving and body care products.
  • CORSAIR® acquires SCUF Gaming®Jones Day advised CORSAIR® in connection with the acquisition and related financing of high-performance controller pioneer SCUF Gaming "SCUF®" and its extensive patent portfolio.
  • Western Digital sells IntelliFlash™ business to DataDirect Networks, Inc. (DDN®)Jones Day advised Western Digital Corp. in the sale of its IntelliFlash™ business to DataDirect Networks, Inc. (DDN®), a global leader in artificial intelligence (AI) and multi-cloud data management.
  • Sumitomo Heavy Industries to acquire InvertekJones Day is advising Sumitomo Heavy Industries, Ltd. in the acquisition of the entire issued share capital of Invertek Drives Ltd.
  • Loungers completes £185 million IPO on AIMJones Day represented Loungers plc, an operator of 146 cafés, bars, and restaurants across England and Wales, in connection with its £185 million (US$239 million) initial public offering on the Alternative Investment Market of the London Stock Exchange.
  • Roper Technologies acquires Foundry for £410 million (US$543.4 million)Jones Day advised Roper Technologies, Inc. in its acquisition of Foundry in an all-cash transaction valued at £410 million (US$543.4 million).
  • Park Place Technologies acquires UK-based third-party maintenance provider MCSA Group LimitedJones Day advised Park Place Technologies in its acquisition of MCSA Group Limited, a UK-based, business-critical IT services and solutions provider.
  • ANSYS acquires Granta Design LimitedJones Day advised ANSYS, Inc., the global leader and innovator of engineering simulation software, in their acquisition of Granta Design, the premier provider of materials information technology, and Granta Design Limited has become a wholly-owned subsidiary of ANSYS.
  • Huadong Medicine announces £169 million (US$222 million) takeover offer for and acquisition of Sinclair Pharma PlcJones Day advised Huadong Medicine Co. Ltd. ("HMC") and its subsidiary, Huadong Medicine Aesthetics Investment (HongKong) Limited ("Huadong"), on Huadong's takeover offer for and acquisition of Sinclair Pharma Plc with a total value of approximately £169 million (US$222 million).
  • Celgene defends its leading product Revlimid® against patent revocation actions in UKJones Day acted for Celgene Corporation in multiple cases brought by Accord Healthcare in the UK High Court (patents court) in relation to Celgene's patents concerning its best-selling drug, Revlimid®.
  • True Capital Ltd completes buyout of Cut4ClothJones Day represented True Capital Ltd in connection with its buyout of Cut4Cloth Ltd. trading as Frugi, a retailer of organic children's clothing, toys, and accessories, alongside existing management.
  • CVC Capital Partners acquires Teva's International Women's Health assets for $703 millionJones Day advised CVC Capital Partners in its $703 million acquisition of Teva Pharmaceutical Industries Ltd's International (non-US), Women's Health assets.
  • Oxenwood Real Estate acquires £286 million (US$366.9 million) Ultrabox logistics portfolioJones Day advised Oxenwood Real Estate LLP on its joint venture with a Canadian institutional investor and the acquisition by that joint venture of the Ultrabox portfolio of nine prime logistics assets in the UK totaling 3.87 million sq. ft. for £286 million (US$366.9 million).
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.